Home > Drug Search >
  • company_query: Affibody
  •   > 
Drug Filter
Category:
chemistry (11) biology (22)
Status:
Approved (7) Phase Ⅲ (2) Phase Ⅱ (9) Phase Ⅰ (15)
Clinical Stage:
Pending (8) Active (9) Discontinued (9)
Bio-Type:
Gene therapy (2) Vaccine (11) Recombinant cytokines (4)
Indication:
Alzheimer's disease (AD) (1) Anemia (1) Arthritis (1) Atopic dermatitis (1) Breast cancer (1) wound (1) HBV infection (1) HIV infection (5) Hypertension (1) Melanoma (2) Multiple myeloma (MM) (1) Neuropathic pain (1) Non-Hodgkin’s lymphoma (NHL) (1) Bone disorders (1) Perennial allergic rhinitis (1) Psoriasis (1) Rheumatoid arthritis (RA) (1) Seasonal allergic rhinitis (1) Smoking cessation (1) Solid tumours (3) Urinary tract infections (1) Coronavirus infection (1) Hodgkin lymphoma (1) Ankylosing Spondylitis (AS) (1) Age-related macular degeneration (AMD) (1) Pain (1) Acute gouty arthritis (GA) (1) Neutropenia (3) Allergic asthma (1) Fractures (2) Burns (1) Brain cancer (1) Ebola virus disease (EVD) (2) Myocardia ischemia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top